2010
DOI: 10.1007/s00431-010-1165-z
|View full text |Cite
|
Sign up to set email alerts
|

Cushing’s syndrome and adrenal insufficiency after intradermal triamcinolone acetonide for keloid scars

Abstract: A 6-year-old girl was admitted to our hospital for excessive weight gain. On presentation, she had a typical Cushingoid appearance and hypertension. Laboratory analysis was indicative for an exogenous glucocorticoid source, showing values that were low for serum cortisol and adrenocorticotropin and for 24-h urinary glucocorticoid (metabolite) excretion. Five and 2 months before presentation, she was treated with intradermal triamcinolone acetonide for keloid scars. Recovery of intrinsic cortisol production occ… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
17
0
1

Year Published

2013
2013
2022
2022

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 29 publications
(18 citation statements)
references
References 6 publications
0
17
0
1
Order By: Relevance
“…Similarly, in our study, half the patients who used exogenous steroids were documented as having AI. Cushingoid appearance in individuals with AI who also use corticosteroids has been described in multiple case reports of topical steroid therapy [23,24]. High-dose or chronic glucocorticoid use from prescribed or surreptitious use can result in Cushingoid appearance.…”
Section: Discussionmentioning
confidence: 99%
“…Similarly, in our study, half the patients who used exogenous steroids were documented as having AI. Cushingoid appearance in individuals with AI who also use corticosteroids has been described in multiple case reports of topical steroid therapy [23,24]. High-dose or chronic glucocorticoid use from prescribed or surreptitious use can result in Cushingoid appearance.…”
Section: Discussionmentioning
confidence: 99%
“…Triamcinolone can be administered by an intraarticular, intralesional, topical, or intramuscular route. Triamcinolone is intermediate-acting and is 5 times more potent than cortisol, so injections, such as the one given to our patient, can have harmful side effects (6). The biological half-life of triamcinolone is 18 to 36 hours, but the preparation can contribute to wide variations (7).…”
Section: Discussionmentioning
confidence: 99%
“…In rare occasions Cushing’s syndrome is related to topical treatment of uveitis4 or intradermal treatment with triamcinolone acetonide 5…”
Section: Discussionmentioning
confidence: 99%